Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 8/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 8/20 | 0.35 |
| ▸ | RELA | Q04206 | 8/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | GAPDH | P04406 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20342972 | 0.94 | NFKB1 (0.40) | ELANEKMT2AATMNFKB1NFKB2 | |
| SCHEMBL21475262 | 0.93 | ELANE (0.36) | ELANEKMT2AATMCA2ESR1 | |
| SCHEMBL2182312 | 0.88 | CA2 (0.44) | KMT2ANFKB1NFKB2RELACA2 | |
| SCHEMBL22842309 | 0.86 | ELANE (0.38) | ELANEKMT2AATMNFKB1NFKB2 | |
| SCHEMBL18647054 | 0.84 | POLB (0.38) | ELANEKMT2AATMCA2 | |
| SCHEMBL18869323 | 0.83 | THRB (0.36) | NFKB1NFKB2RELAESR1ESR2 | |
| SCHEMBL12413283 | 0.80 | LMNA (0.45) | KMT2ANFKB1NFKB2RELACA2 | |
| SCHEMBL18808263 | 0.79 | NFKB1 (0.38) | NFKB1NFKB2RELA | |
| SCHEMBL22003141 | 0.79 | POLB (0.37) | ELANECA2 | |
| SCHEMBL13970428 | 0.77 | CA2 (0.43) | KMT2ANFKB1NFKB2RELACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3924447-B1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2024-01-24 | — | — | EP | disclosed |
| WO-2023198673-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-10-19 | — | — | WO | disclosed |
| EP-4209566-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2023-07-12 | — | — | EP | disclosed |
| EP-4209568-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2023-07-12 | — | — | EP | disclosed |
| US-11072742-B2 | Liquid-crystalline media having homeotropic alignment | MERCK PATENT GMBH (DE) | 2021-07-27 | — | — | US | disclosed |
| WO-2020229434-A1 | METHOD FOR PREPARING A LIQUID CRYSTAL-BASED SWITCHING ELEMENT | MERCK PATENT GMBH (DE) | 2020-11-19 | — | — | WO | disclosed |
| EP-3428246-B1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2020-04-15 | — | — | EP | disclosed |
| EP-3604481-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2020-02-05 | — | — | EP | disclosed |
| EP-3502210-A1 | LIQUID-CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2019-06-26 | — | — | EP | disclosed |
| US-20190185754-A1 | LIQUID-CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT | MERCK PATENT GMBH (DE) | 2019-06-20 | — | — | US | disclosed |
| EP-2985334-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2018-06-20 | — | — | EP | disclosed |
| EP-2848676-B1 | Liquid crystal medium | MERCK PATENT GMBH (DE) | 2017-07-26 | — | — | EP | disclosed |
| EP-3130651-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2017-02-15 | — | — | EP | disclosed |